REZUROCK can be an inhibitor of UGT1A1. Coadministration of REZUROCK that has a UGT1A1 substrate diminished plasma concentrations with the glucuronide metabolite, which can increase the chance of adverse reactions relevant to delicate substrates of UGT1A1An engineering method of express genes encoding designer receptors in cells in order to have th